MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a science and technology company, has strengthened its manufacturing capabilities for single-use assemblies, a key technology for the production of Covid-19 vaccines and other therapies, by investing € 130 million in Molsheim, France. The investment is the largest ever in the 50-year history of the site and will create more than 800 jobs by the end of 2028.   The expansion will further increase capacit...